In his latest column, DSN editor-in-chief Nigel Maynard takes a look back at 2022 and a peek into next year.

In his latest column, DSN editor-in-chief Nigel Maynard ask readers to stop and reflect on women’s contributions to retail pharmacy.

In his latest column, DSN editor-in-chief Nigel Maynard asks readers to share personalized stories of individuals or stores that went above and beyond.

DSN editor and chief Nigel F. Maynard reviews how the retail pharmacy industry needs to plan for the next chapter in its storyline.

In his latest column, DSN editor-in-chief Nigel Maynard points out how retail pharmacy expanded its scope during the pandemic, but sees its greatest impact at the state level.

DSN editor and chief Nigel Maynard discusses a study on the direct and indirect implications for retail pharmacy and the push toward health care.

In his latest column, DSN editor and chief Nigel Maynard highlights how some retail pharmacies are reexamining their SKUs as healthcare services expand and supply chain constraints cause a shortage of new products.

DSN editor in chief Nigel Maynard reveals how DIR fees are seen as the most challenging issue the industry faces.

In his latest column, DSN editor and chief Nigel Maynard points to retail pharmacy’s biggest advantage in its arsenal of tools when competing with rivals.

DSN editor in chief Nigel Maynard shares how a panel of consultants, suppliers and pharmacy executives discussed possible solutions to some of the issues the industry is facing.

In his latest column, DSN editor and chief Nigel Maynard previews a panel of executives weighing in on where retail pharmacy stands, where it’s going, and how it must adapt and evolve to get there.

DSN editor and chief Nigel Maynard examines the sweeping changes impacting the retail pharmacy industry in 2022.